STETZ GARY S. II purchased 500K shares of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $25.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/13/2026ACC: 0001493152-26-037500
Director
Since Jul 2026
+1M
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+500K
Price / share
$0.05
Trade value
$25K
% of position
New position
8/3/2026
0.00→500K
Total
Net shares
+500K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | P · Purchase | +500K | $0.05 | $25K | New position | 0.00 | 500K |
| Total | +500K | $25K | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Stock
500K shares
Shares
+500K
Strike price
0.06
Held after
500K
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Stock500K shares | 8/3/2026 | P · Purchase | +500K | 0.06 | — | 500K |